nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—HTR2C—bipolar disorder	0.528	1	CbGaD
Sorafenib—Regorafenib—NTRK1—bipolar disorder	0.00887	1	CrCbGaD
Sorafenib—RET—autonomic nervous system—bipolar disorder	0.0075	0.0354	CbGeAlD
Sorafenib—UGT1A1—urine—bipolar disorder	0.00481	0.0227	CbGeAlD
Sorafenib—FLT3—blood plasma—bipolar disorder	0.00398	0.0188	CbGeAlD
Sorafenib—MUSK—nervous system—bipolar disorder	0.00384	0.0182	CbGeAlD
Sorafenib—HTR2C—telencephalic ventricle—bipolar disorder	0.00363	0.0172	CbGeAlD
Sorafenib—MAPK15—thyroid gland—bipolar disorder	0.00335	0.0158	CbGeAlD
Sorafenib—CDKL2—nervous system—bipolar disorder	0.00313	0.0148	CbGeAlD
Sorafenib—RALBP1—blood plasma—bipolar disorder	0.00295	0.014	CbGeAlD
Sorafenib—MAPK15—nervous system—bipolar disorder	0.00282	0.0133	CbGeAlD
Sorafenib—FLT1—blood plasma—bipolar disorder	0.00281	0.0133	CbGeAlD
Sorafenib—STK10—blood plasma—bipolar disorder	0.00266	0.0126	CbGeAlD
Sorafenib—CDKL3—brain—bipolar disorder	0.00262	0.0124	CbGeAlD
Sorafenib—CYP2C19—urine—bipolar disorder	0.00261	0.0123	CbGeAlD
Sorafenib—UGT1A1—blood plasma—bipolar disorder	0.00251	0.0119	CbGeAlD
Sorafenib—CDKL2—brain—bipolar disorder	0.00239	0.0113	CbGeAlD
Sorafenib—KDR—blood plasma—bipolar disorder	0.00237	0.0112	CbGeAlD
Sorafenib—CSF1R—blood plasma—bipolar disorder	0.00232	0.011	CbGeAlD
Sorafenib—TIE1—adrenal cortex—bipolar disorder	0.00222	0.0105	CbGeAlD
Sorafenib—MAPK15—brain—bipolar disorder	0.00215	0.0102	CbGeAlD
Sorafenib—CYP1A2—urine—bipolar disorder	0.00213	0.0101	CbGeAlD
Sorafenib—KIT—blood plasma—bipolar disorder	0.0021	0.00995	CbGeAlD
Sorafenib—EPHX2—adrenal cortex—bipolar disorder	0.00203	0.00961	CbGeAlD
Sorafenib—CYP2C9—urine—bipolar disorder	0.00202	0.00956	CbGeAlD
Sorafenib—MAPK11—thyroid gland—bipolar disorder	0.00199	0.0094	CbGeAlD
Sorafenib—CDK7—thyroid gland—bipolar disorder	0.00195	0.00925	CbGeAlD
Sorafenib—TAOK2—thyroid gland—bipolar disorder	0.00194	0.00917	CbGeAlD
Sorafenib—AURKC—thyroid gland—bipolar disorder	0.00192	0.0091	CbGeAlD
Sorafenib—FLT4—adrenal cortex—bipolar disorder	0.00183	0.00867	CbGeAlD
Sorafenib—MAP3K7—adrenal cortex—bipolar disorder	0.00171	0.0081	CbGeAlD
Sorafenib—ZAK—thyroid gland—bipolar disorder	0.00169	0.00799	CbGeAlD
Sorafenib—MAPK11—nervous system—bipolar disorder	0.00167	0.0079	CbGeAlD
Sorafenib—MKNK2—adrenal cortex—bipolar disorder	0.00166	0.00785	CbGeAlD
Sorafenib—HIPK3—thyroid gland—bipolar disorder	0.00165	0.00782	CbGeAlD
Sorafenib—CDK7—nervous system—bipolar disorder	0.00164	0.00778	CbGeAlD
Sorafenib—MKNK1—adrenal cortex—bipolar disorder	0.00164	0.00775	CbGeAlD
Sorafenib—ABCC4—blood plasma—bipolar disorder	0.00164	0.00774	CbGeAlD
Sorafenib—AURKC—nervous system—bipolar disorder	0.00162	0.00766	CbGeAlD
Sorafenib—MAPK11—cerebellum—bipolar disorder	0.00157	0.00744	CbGeAlD
Sorafenib—CDK7—cerebellum—bipolar disorder	0.00155	0.00732	CbGeAlD
Sorafenib—TIE1—thyroid gland—bipolar disorder	0.00155	0.00731	CbGeAlD
Sorafenib—CYP3A4—urine—bipolar disorder	0.00154	0.00729	CbGeAlD
Sorafenib—TAOK2—cerebellum—bipolar disorder	0.00154	0.00726	CbGeAlD
Sorafenib—CYP2D6—urine—bipolar disorder	0.00152	0.00717	CbGeAlD
Sorafenib—EPHA6—nervous system—bipolar disorder	0.0015	0.00709	CbGeAlD
Sorafenib—RALBP1—adrenal cortex—bipolar disorder	0.0015	0.00709	CbGeAlD
Sorafenib—BRAF—thyroid gland—bipolar disorder	0.00148	0.00701	CbGeAlD
Sorafenib—HIPK4—brain—bipolar disorder	0.00145	0.00686	CbGeAlD
Sorafenib—FLT1—adrenal cortex—bipolar disorder	0.00143	0.00674	CbGeAlD
Sorafenib—ZAK—nervous system—bipolar disorder	0.00142	0.00672	CbGeAlD
Sorafenib—RAF1—adrenal cortex—bipolar disorder	0.00142	0.0067	CbGeAlD
Sorafenib—EPHX2—thyroid gland—bipolar disorder	0.00142	0.0067	CbGeAlD
Sorafenib—MAP3K19—nervous system—bipolar disorder	0.00136	0.00644	CbGeAlD
Sorafenib—CYP2C19—blood plasma—bipolar disorder	0.00136	0.00644	CbGeAlD
Sorafenib—ZAK—cerebellum—bipolar disorder	0.00134	0.00632	CbGeAlD
Sorafenib—HIPK3—cerebellum—bipolar disorder	0.00131	0.00619	CbGeAlD
Sorafenib—TIE1—nervous system—bipolar disorder	0.0013	0.00615	CbGeAlD
Sorafenib—MAPK11—brain—bipolar disorder	0.00128	0.00604	CbGeAlD
Sorafenib—FLT4—thyroid gland—bipolar disorder	0.00128	0.00604	CbGeAlD
Sorafenib—FGFR1—thyroid gland—bipolar disorder	0.00126	0.00596	CbGeAlD
Sorafenib—CDK7—brain—bipolar disorder	0.00126	0.00594	CbGeAlD
Sorafenib—TAOK2—brain—bipolar disorder	0.00125	0.0059	CbGeAlD
Sorafenib—AURKC—brain—bipolar disorder	0.00124	0.00585	CbGeAlD
Sorafenib—TIE1—cerebellum—bipolar disorder	0.00122	0.00578	CbGeAlD
Sorafenib—KDR—adrenal cortex—bipolar disorder	0.0012	0.0057	CbGeAlD
Sorafenib—MAP2K5—adrenal cortex—bipolar disorder	0.0012	0.0057	CbGeAlD
Sorafenib—MAP3K7—thyroid gland—bipolar disorder	0.00119	0.00564	CbGeAlD
Sorafenib—CYP2C8—blood plasma—bipolar disorder	0.00119	0.00562	CbGeAlD
Sorafenib—CSF1R—adrenal cortex—bipolar disorder	0.00118	0.00556	CbGeAlD
Sorafenib—BRAF—cerebellum—bipolar disorder	0.00117	0.00555	CbGeAlD
Sorafenib—MKNK2—thyroid gland—bipolar disorder	0.00116	0.00547	CbGeAlD
Sorafenib—EPHA6—brain—bipolar disorder	0.00115	0.00542	CbGeAlD
Sorafenib—MKNK1—thyroid gland—bipolar disorder	0.00114	0.0054	CbGeAlD
Sorafenib—RET—thyroid gland—bipolar disorder	0.00113	0.00533	CbGeAlD
Sorafenib—EPHX2—cerebellum—bipolar disorder	0.00112	0.0053	CbGeAlD
Sorafenib—FLT3—cerebellum—bipolar disorder	0.00111	0.00526	CbGeAlD
Sorafenib—CYP1A2—blood plasma—bipolar disorder	0.00111	0.00526	CbGeAlD
Sorafenib—ZAK—brain—bipolar disorder	0.00109	0.00514	CbGeAlD
Sorafenib—CYP3A5—blood plasma—bipolar disorder	0.00107	0.00507	CbGeAlD
Sorafenib—CYP2B6—blood plasma—bipolar disorder	0.00107	0.00504	CbGeAlD
Sorafenib—HIPK3—brain—bipolar disorder	0.00106	0.00503	CbGeAlD
Sorafenib—CYP2C9—blood plasma—bipolar disorder	0.00105	0.00499	CbGeAlD
Sorafenib—RALBP1—thyroid gland—bipolar disorder	0.00104	0.00494	CbGeAlD
Sorafenib—PDGFRB—adrenal cortex—bipolar disorder	0.00104	0.00493	CbGeAlD
Sorafenib—MAP3K19—brain—bipolar disorder	0.00104	0.00492	CbGeAlD
Sorafenib—FGFR1—cerebellum—bipolar disorder	0.000997	0.00472	CbGeAlD
Sorafenib—TIE1—brain—bipolar disorder	0.000994	0.0047	CbGeAlD
Sorafenib—FLT1—thyroid gland—bipolar disorder	0.000993	0.0047	CbGeAlD
Sorafenib—RAF1—thyroid gland—bipolar disorder	0.000987	0.00467	CbGeAlD
Sorafenib—EPHB6—thyroid gland—bipolar disorder	0.000981	0.00464	CbGeAlD
Sorafenib—MKNK2—nervous system—bipolar disorder	0.000972	0.0046	CbGeAlD
Sorafenib—MKNK1—nervous system—bipolar disorder	0.00096	0.00454	CbGeAlD
Sorafenib—BRAF—brain—bipolar disorder	0.000953	0.0045	CbGeAlD
Sorafenib—RET—nervous system—bipolar disorder	0.000948	0.00448	CbGeAlD
Sorafenib—MAP3K7—cerebellum—bipolar disorder	0.000944	0.00446	CbGeAlD
Sorafenib—STK10—thyroid gland—bipolar disorder	0.00094	0.00444	CbGeAlD
Sorafenib—PDGFRA—thyroid gland—bipolar disorder	0.00093	0.0044	CbGeAlD
Sorafenib—MKNK2—cerebellum—bipolar disorder	0.000915	0.00433	CbGeAlD
Sorafenib—EPHX2—brain—bipolar disorder	0.00091	0.0043	CbGeAlD
Sorafenib—MKNK1—cerebellum—bipolar disorder	0.000903	0.00427	CbGeAlD
Sorafenib—RET—cerebellum—bipolar disorder	0.000892	0.00422	CbGeAlD
Sorafenib—RALBP1—nervous system—bipolar disorder	0.000878	0.00415	CbGeAlD
Sorafenib—KDR—thyroid gland—bipolar disorder	0.000839	0.00397	CbGeAlD
Sorafenib—MAP2K5—thyroid gland—bipolar disorder	0.000839	0.00397	CbGeAlD
Sorafenib—FLT1—nervous system—bipolar disorder	0.000835	0.00395	CbGeAlD
Sorafenib—RAF1—nervous system—bipolar disorder	0.00083	0.00393	CbGeAlD
Sorafenib—RALBP1—cerebellum—bipolar disorder	0.000826	0.00391	CbGeAlD
Sorafenib—HTR2B—adrenal cortex—bipolar disorder	0.000826	0.00391	CbGeAlD
Sorafenib—EPHB6—nervous system—bipolar disorder	0.000825	0.0039	CbGeAlD
Sorafenib—FLT4—brain—bipolar disorder	0.000821	0.00388	CbGeAlD
Sorafenib—CSF1R—thyroid gland—bipolar disorder	0.000819	0.00387	CbGeAlD
Sorafenib—FGFR1—brain—bipolar disorder	0.00081	0.00383	CbGeAlD
Sorafenib—CYP3A4—blood plasma—bipolar disorder	0.000804	0.0038	CbGeAlD
Sorafenib—CYP2D6—blood plasma—bipolar disorder	0.000792	0.00374	CbGeAlD
Sorafenib—STK10—nervous system—bipolar disorder	0.000791	0.00374	CbGeAlD
Sorafenib—FLT1—cerebellum—bipolar disorder	0.000786	0.00372	CbGeAlD
Sorafenib—PDGFRA—nervous system—bipolar disorder	0.000783	0.0037	CbGeAlD
Sorafenib—RAF1—cerebellum—bipolar disorder	0.000781	0.00369	CbGeAlD
Sorafenib—EPHB6—cerebellum—bipolar disorder	0.000777	0.00367	CbGeAlD
Sorafenib—MAP3K7—brain—bipolar disorder	0.000767	0.00363	CbGeAlD
Sorafenib—STK10—cerebellum—bipolar disorder	0.000744	0.00352	CbGeAlD
Sorafenib—KIT—thyroid gland—bipolar disorder	0.000744	0.00352	CbGeAlD
Sorafenib—MKNK2—brain—bipolar disorder	0.000743	0.00351	CbGeAlD
Sorafenib—PDGFRA—cerebellum—bipolar disorder	0.000736	0.00348	CbGeAlD
Sorafenib—MKNK1—brain—bipolar disorder	0.000734	0.00347	CbGeAlD
Sorafenib—PDGFRB—thyroid gland—bipolar disorder	0.000726	0.00344	CbGeAlD
Sorafenib—RET—brain—bipolar disorder	0.000725	0.00343	CbGeAlD
Sorafenib—MAP2K5—nervous system—bipolar disorder	0.000706	0.00334	CbGeAlD
Sorafenib—KDR—nervous system—bipolar disorder	0.000706	0.00334	CbGeAlD
Sorafenib—CSF1R—nervous system—bipolar disorder	0.000689	0.00326	CbGeAlD
Sorafenib—RALBP1—brain—bipolar disorder	0.000671	0.00317	CbGeAlD
Sorafenib—MAP2K5—cerebellum—bipolar disorder	0.000664	0.00314	CbGeAlD
Sorafenib—KDR—cerebellum—bipolar disorder	0.000664	0.00314	CbGeAlD
Sorafenib—CSF1R—cerebellum—bipolar disorder	0.000648	0.00307	CbGeAlD
Sorafenib—FLT1—brain—bipolar disorder	0.000638	0.00302	CbGeAlD
Sorafenib—RAF1—brain—bipolar disorder	0.000635	0.003	CbGeAlD
Sorafenib—EPHB6—brain—bipolar disorder	0.000631	0.00298	CbGeAlD
Sorafenib—KIT—nervous system—bipolar disorder	0.000626	0.00296	CbGeAlD
Sorafenib—PDGFRB—nervous system—bipolar disorder	0.000611	0.00289	CbGeAlD
Sorafenib—STK10—brain—bipolar disorder	0.000604	0.00286	CbGeAlD
Sorafenib—PDGFRA—brain—bipolar disorder	0.000598	0.00283	CbGeAlD
Sorafenib—KIT—cerebellum—bipolar disorder	0.000589	0.00278	CbGeAlD
Sorafenib—ABCG2—adrenal cortex—bipolar disorder	0.000586	0.00277	CbGeAlD
Sorafenib—ABCC4—thyroid gland—bipolar disorder	0.000578	0.00274	CbGeAlD
Sorafenib—HTR2B—thyroid gland—bipolar disorder	0.000575	0.00272	CbGeAlD
Sorafenib—PDGFRB—cerebellum—bipolar disorder	0.000575	0.00272	CbGeAlD
Sorafenib—ABCB1—blood plasma—bipolar disorder	0.000569	0.00269	CbGeAlD
Sorafenib—CYP2B6—adrenal cortex—bipolar disorder	0.000541	0.00256	CbGeAlD
Sorafenib—MAP2K5—brain—bipolar disorder	0.00054	0.00255	CbGeAlD
Sorafenib—KDR—brain—bipolar disorder	0.00054	0.00255	CbGeAlD
Sorafenib—CSF1R—brain—bipolar disorder	0.000527	0.00249	CbGeAlD
Sorafenib—HTR2C—nervous system—bipolar disorder	0.000515	0.00244	CbGeAlD
Sorafenib—ABCC4—nervous system—bipolar disorder	0.000487	0.0023	CbGeAlD
Sorafenib—HTR2B—nervous system—bipolar disorder	0.000484	0.00229	CbGeAlD
Sorafenib—KIT—brain—bipolar disorder	0.000478	0.00226	CbGeAlD
Sorafenib—PDGFRB—brain—bipolar disorder	0.000467	0.00221	CbGeAlD
Sorafenib—ABCG2—thyroid gland—bipolar disorder	0.000408	0.00193	CbGeAlD
Sorafenib—HTR2C—brain—bipolar disorder	0.000394	0.00186	CbGeAlD
Sorafenib—CYP1A2—thyroid gland—bipolar disorder	0.000393	0.00186	CbGeAlD
Sorafenib—ABCC4—brain—bipolar disorder	0.000372	0.00176	CbGeAlD
Sorafenib—HTR2B—brain—bipolar disorder	0.00037	0.00175	CbGeAlD
Sorafenib—ABCG2—cerebellum—bipolar disorder	0.000323	0.00153	CbGeAlD
Sorafenib—CYP2B6—nervous system—bipolar disorder	0.000317	0.0015	CbGeAlD
Sorafenib—ABCB1—adrenal cortex—bipolar disorder	0.000289	0.00137	CbGeAlD
Sorafenib—CYP2C8—brain—bipolar disorder	0.00027	0.00128	CbGeAlD
Sorafenib—ABCG2—brain—bipolar disorder	0.000263	0.00124	CbGeAlD
Sorafenib—CYP2B6—brain—bipolar disorder	0.000242	0.00115	CbGeAlD
Sorafenib—CYP3A4—nervous system—bipolar disorder	0.000239	0.00113	CbGeAlD
Sorafenib—CYP2D6—nervous system—bipolar disorder	0.000235	0.00111	CbGeAlD
Sorafenib—CYP2D6—cerebellum—bipolar disorder	0.000222	0.00105	CbGeAlD
Sorafenib—ABCB1—thyroid gland—bipolar disorder	0.000201	0.000952	CbGeAlD
Sorafenib—CYP2D6—brain—bipolar disorder	0.00018	0.000851	CbGeAlD
Sorafenib—ABCB1—nervous system—bipolar disorder	0.000169	0.000801	CbGeAlD
Sorafenib—ABCB1—cerebellum—bipolar disorder	0.000159	0.000754	CbGeAlD
Sorafenib—ABCB1—brain—bipolar disorder	0.000129	0.000612	CbGeAlD
Sorafenib—KIT—Disease—GSK3B—bipolar disorder	1.5e-05	5.94e-05	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—MAOA—bipolar disorder	1.49e-05	5.92e-05	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—MAOA—bipolar disorder	1.49e-05	5.92e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—ADCY2—bipolar disorder	1.49e-05	5.91e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—DPYD—bipolar disorder	1.48e-05	5.89e-05	CbGpPWpGaD
Sorafenib—KIT—Disease—INS—bipolar disorder	1.48e-05	5.86e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ADCY2—bipolar disorder	1.48e-05	5.86e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	1.45e-05	5.74e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—NRG1—bipolar disorder	1.44e-05	5.73e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—NRG1—bipolar disorder	1.44e-05	5.73e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HTR2A—bipolar disorder	1.44e-05	5.73e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	1.44e-05	5.72e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—IMPA1—bipolar disorder	1.44e-05	5.7e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NTRK1—bipolar disorder	1.43e-05	5.69e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—POMC—bipolar disorder	1.43e-05	5.68e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HTR2A—bipolar disorder	1.43e-05	5.67e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—ADCY2—bipolar disorder	1.43e-05	5.66e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TCF7L2—bipolar disorder	1.42e-05	5.64e-05	CbGpPWpGaD
Sorafenib—FGFR1—Disease—GSK3B—bipolar disorder	1.42e-05	5.64e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TAC1—bipolar disorder	1.42e-05	5.63e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—GSK3B—bipolar disorder	1.42e-05	5.62e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—DRD2—bipolar disorder	1.41e-05	5.61e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CACNA1C—bipolar disorder	1.41e-05	5.6e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—MTHFR—bipolar disorder	1.41e-05	5.6e-05	CbGpPWpGaD
Sorafenib—FGFR1—Disease—INS—bipolar disorder	1.4e-05	5.56e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—INS—bipolar disorder	1.4e-05	5.55e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—S100B—bipolar disorder	1.39e-05	5.54e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—DRD1—bipolar disorder	1.39e-05	5.52e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—GSK3B—bipolar disorder	1.39e-05	5.5e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—GSK3B—bipolar disorder	1.38e-05	5.49e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CACNA1C—bipolar disorder	1.38e-05	5.47e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—NR1D1—bipolar disorder	1.38e-05	5.46e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—POMC—bipolar disorder	1.38e-05	5.46e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PIK3C2A—bipolar disorder	1.37e-05	5.46e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—NRG1—bipolar disorder	1.37e-05	5.44e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NTRK1—bipolar disorder	1.37e-05	5.43e-05	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—INS—bipolar disorder	1.37e-05	5.43e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—NRG1—bipolar disorder	1.37e-05	5.42e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	1.35e-05	5.37e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—GSK3B—bipolar disorder	1.35e-05	5.36e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—DRD3—bipolar disorder	1.35e-05	5.35e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	1.34e-05	5.33e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	1.34e-05	5.33e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—POMC—bipolar disorder	1.34e-05	5.32e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CLOCK—bipolar disorder	1.34e-05	5.32e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—POMC—bipolar disorder	1.34e-05	5.31e-05	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—INS—bipolar disorder	1.33e-05	5.29e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—S100B—bipolar disorder	1.33e-05	5.28e-05	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IL1B—bipolar disorder	1.32e-05	5.25e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—NCAN—bipolar disorder	1.32e-05	5.22e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—DRD4—bipolar disorder	1.31e-05	5.19e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—TPH2—bipolar disorder	1.31e-05	5.18e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CACNB2—bipolar disorder	1.31e-05	5.18e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—TSHB—bipolar disorder	1.31e-05	5.18e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HTR2A—bipolar disorder	1.3e-05	5.17e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HTR2A—bipolar disorder	1.3e-05	5.17e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—SLC5A3—bipolar disorder	1.29e-05	5.12e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—DPYD—bipolar disorder	1.28e-05	5.1e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NTRK1—bipolar disorder	1.28e-05	5.08e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—GSK3B—bipolar disorder	1.28e-05	5.06e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—COMT—bipolar disorder	1.27e-05	5.06e-05	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	1.27e-05	5.05e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—MAOA—bipolar disorder	1.27e-05	5.02e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—COMT—bipolar disorder	1.26e-05	5.01e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—INS—bipolar disorder	1.26e-05	5e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—MAOA—bipolar disorder	1.25e-05	4.98e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—S100B—bipolar disorder	1.24e-05	4.93e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HTR2A—bipolar disorder	1.24e-05	4.9e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—SNAP25—bipolar disorder	1.23e-05	4.89e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	1.23e-05	4.89e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HTR2A—bipolar disorder	1.23e-05	4.89e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—GSK3B—bipolar disorder	1.23e-05	4.89e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NRG1—bipolar disorder	1.23e-05	4.89e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	1.23e-05	4.87e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.22e-05	4.84e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—DRD2—bipolar disorder	1.22e-05	4.84e-05	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—MTHFR—bipolar disorder	1.21e-05	4.82e-05	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—MTHFR—bipolar disorder	1.21e-05	4.82e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—SNAP25—bipolar disorder	1.21e-05	4.78e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CLOCK—bipolar disorder	1.2e-05	4.75e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CACNA1C—bipolar disorder	1.19e-05	4.74e-05	CbGpPWpGaD
Sorafenib—KIT—Immune System—IL1B—bipolar disorder	1.19e-05	4.73e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IL1B—bipolar disorder	1.19e-05	4.73e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	1.18e-05	4.69e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NRG1—bipolar disorder	1.17e-05	4.66e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CLOCK—bipolar disorder	1.17e-05	4.63e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—TSHB—bipolar disorder	1.17e-05	4.63e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—TPH2—bipolar disorder	1.17e-05	4.63e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CACNB2—bipolar disorder	1.17e-05	4.63e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	1.16e-05	4.62e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—GSK3B—bipolar disorder	1.16e-05	4.61e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—POMC—bipolar disorder	1.15e-05	4.58e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—POMC—bipolar disorder	1.15e-05	4.57e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—GSK3B—bipolar disorder	1.15e-05	4.57e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.15e-05	4.56e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—DPYD—bipolar disorder	1.15e-05	4.55e-05	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—INS—bipolar disorder	1.15e-05	4.55e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—POMC—bipolar disorder	1.14e-05	4.53e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—TPH2—bipolar disorder	1.14e-05	4.51e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—TSHB—bipolar disorder	1.14e-05	4.51e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CACNB2—bipolar disorder	1.14e-05	4.51e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—GSK3B—bipolar disorder	1.14e-05	4.51e-05	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—INS—bipolar disorder	1.14e-05	4.51e-05	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IL1B—bipolar disorder	1.13e-05	4.49e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IL1B—bipolar disorder	1.13e-05	4.48e-05	CbGpPWpGaD
Sorafenib—RAF1—Disease—INS—bipolar disorder	1.12e-05	4.45e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—DPYD—bipolar disorder	1.12e-05	4.44e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HTR2A—bipolar disorder	1.11e-05	4.4e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	1.1e-05	4.38e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.1e-05	4.37e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NRG1—bipolar disorder	1.1e-05	4.35e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ADCY2—bipolar disorder	1.09e-05	4.33e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CLOCK—bipolar disorder	1.09e-05	4.33e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—S100B—bipolar disorder	1.07e-05	4.26e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—TSHB—bipolar disorder	1.07e-05	4.25e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—TPH2—bipolar disorder	1.07e-05	4.25e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.07e-05	4.25e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ADCY2—bipolar disorder	1.07e-05	4.23e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CACNA1C—bipolar disorder	1.07e-05	4.23e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—TPH2—bipolar disorder	1.06e-05	4.22e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—TSHB—bipolar disorder	1.06e-05	4.22e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CACNB2—bipolar disorder	1.06e-05	4.22e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.06e-05	4.21e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HTR2A—bipolar disorder	1.06e-05	4.2e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—DPYD—bipolar disorder	1.05e-05	4.19e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—GSK3B—bipolar disorder	1.05e-05	4.16e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—GSK3B—bipolar disorder	1.05e-05	4.16e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—DPYD—bipolar disorder	1.05e-05	4.15e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—SNAP25—bipolar disorder	1.04e-05	4.14e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CACNA1C—bipolar disorder	1.04e-05	4.13e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—POMC—bipolar disorder	1.04e-05	4.12e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—POMC—bipolar disorder	1.04e-05	4.12e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	1.04e-05	4.12e-05	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—INS—bipolar disorder	1.03e-05	4.1e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—INS—bipolar disorder	1.03e-05	4.1e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—MTHFR—bipolar disorder	1.03e-05	4.09e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.03e-05	4.07e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—MTHFR—bipolar disorder	1.02e-05	4.05e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL1B—bipolar disorder	1.02e-05	4.04e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NCAN—bipolar disorder	1.02e-05	4.03e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	1.01e-05	4.02e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	9.95e-06	3.95e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—GSK3B—bipolar disorder	9.94e-06	3.95e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—GSK3B—bipolar disorder	9.92e-06	3.94e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HTR2A—bipolar disorder	9.89e-06	3.93e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—POMC—bipolar disorder	9.86e-06	3.91e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—POMC—bipolar disorder	9.84e-06	3.9e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—INS—bipolar disorder	9.81e-06	3.89e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CACNA1C—bipolar disorder	9.81e-06	3.89e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—INS—bipolar disorder	9.78e-06	3.88e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CACNA1C—bipolar disorder	9.72e-06	3.86e-05	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—POMC—bipolar disorder	9.71e-06	3.85e-05	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—POMC—bipolar disorder	9.71e-06	3.85e-05	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—INS—bipolar disorder	9.66e-06	3.83e-05	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—INS—bipolar disorder	9.66e-06	3.83e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	9.56e-06	3.79e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	9.47e-06	3.76e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NRG1—bipolar disorder	9.47e-06	3.76e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	9.35e-06	3.71e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—COMT—bipolar disorder	9.35e-06	3.71e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CLOCK—bipolar disorder	9.32e-06	3.7e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—SNAP25—bipolar disorder	9.32e-06	3.7e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—MAOA—bipolar disorder	9.28e-06	3.68e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ADCY2—bipolar disorder	9.24e-06	3.67e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—COMT—bipolar disorder	9.13e-06	3.62e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—SNAP25—bipolar disorder	9.1e-06	3.61e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—TPH2—bipolar disorder	9.08e-06	3.6e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—TSHB—bipolar disorder	9.08e-06	3.6e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CACNB2—bipolar disorder	9.08e-06	3.6e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—MAOA—bipolar disorder	9.07e-06	3.6e-05	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL1B—bipolar disorder	9.07e-06	3.6e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—GSK3B—bipolar disorder	8.94e-06	3.55e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—DPYD—bipolar disorder	8.94e-06	3.55e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—POMC—bipolar disorder	8.86e-06	3.52e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—INS—bipolar disorder	8.82e-06	3.5e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—SNAP25—bipolar disorder	8.57e-06	3.4e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	8.54e-06	3.39e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—GSK3B—bipolar disorder	8.52e-06	3.38e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—SNAP25—bipolar disorder	8.5e-06	3.37e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—POMC—bipolar disorder	8.45e-06	3.35e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—INS—bipolar disorder	8.41e-06	3.34e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CACNA1C—bipolar disorder	8.31e-06	3.3e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ADCY2—bipolar disorder	8.25e-06	3.27e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—POMC—bipolar disorder	8.24e-06	3.27e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—INS—bipolar disorder	8.2e-06	3.25e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—POMC—bipolar disorder	8.17e-06	3.24e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—INS—bipolar disorder	8.12e-06	3.22e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	8.1e-06	3.21e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ADCY2—bipolar disorder	8.05e-06	3.19e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	7.99e-06	3.17e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—GSK3B—bipolar disorder	7.97e-06	3.16e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—COMT—bipolar disorder	7.91e-06	3.14e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—POMC—bipolar disorder	7.9e-06	3.14e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—INS—bipolar disorder	7.86e-06	3.12e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—MAOA—bipolar disorder	7.86e-06	3.12e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ADCY2—bipolar disorder	7.59e-06	3.01e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—MTHFR—bipolar disorder	7.55e-06	3e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ADCY2—bipolar disorder	7.52e-06	2.98e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—MTHFR—bipolar disorder	7.38e-06	2.93e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—SNAP25—bipolar disorder	7.26e-06	2.88e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CLOCK—bipolar disorder	7.19e-06	2.85e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—COMT—bipolar disorder	7.06e-06	2.8e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—MAOA—bipolar disorder	7.01e-06	2.78e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—TPH2—bipolar disorder	7.01e-06	2.78e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—TSHB—bipolar disorder	7.01e-06	2.78e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CACNB2—bipolar disorder	7.01e-06	2.78e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—DPYD—bipolar disorder	6.9e-06	2.74e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—COMT—bipolar disorder	6.89e-06	2.74e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	6.88e-06	2.73e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—MAOA—bipolar disorder	6.84e-06	2.72e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—POMC—bipolar disorder	6.82e-06	2.71e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—INS—bipolar disorder	6.78e-06	2.69e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—COMT—bipolar disorder	6.5e-06	2.58e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—MAOA—bipolar disorder	6.45e-06	2.56e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—COMT—bipolar disorder	6.44e-06	2.56e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ADCY2—bipolar disorder	6.43e-06	2.55e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	6.41e-06	2.54e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—MTHFR—bipolar disorder	6.4e-06	2.54e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—MAOA—bipolar disorder	6.39e-06	2.54e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	6.25e-06	2.48e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—POMC—bipolar disorder	6.04e-06	2.4e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—INS—bipolar disorder	6.01e-06	2.38e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—POMC—bipolar disorder	5.91e-06	2.34e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—INS—bipolar disorder	5.87e-06	2.33e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—MTHFR—bipolar disorder	5.71e-06	2.27e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—SNAP25—bipolar disorder	5.6e-06	2.22e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—MTHFR—bipolar disorder	5.57e-06	2.21e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—COMT—bipolar disorder	5.5e-06	2.18e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—MAOA—bipolar disorder	5.46e-06	2.17e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—MTHFR—bipolar disorder	5.25e-06	2.08e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—MTHFR—bipolar disorder	5.2e-06	2.07e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—POMC—bipolar disorder	5.11e-06	2.03e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—INS—bipolar disorder	5.09e-06	2.02e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ADCY2—bipolar disorder	4.96e-06	1.97e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—POMC—bipolar disorder	4.57e-06	1.81e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—INS—bipolar disorder	4.54e-06	1.8e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—POMC—bipolar disorder	4.46e-06	1.77e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—MTHFR—bipolar disorder	4.45e-06	1.77e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—INS—bipolar disorder	4.43e-06	1.76e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—COMT—bipolar disorder	4.25e-06	1.69e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—MAOA—bipolar disorder	4.22e-06	1.67e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—POMC—bipolar disorder	4.2e-06	1.67e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—INS—bipolar disorder	4.18e-06	1.66e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—POMC—bipolar disorder	4.16e-06	1.65e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—INS—bipolar disorder	4.14e-06	1.64e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—POMC—bipolar disorder	3.56e-06	1.41e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—INS—bipolar disorder	3.54e-06	1.4e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—MTHFR—bipolar disorder	3.43e-06	1.36e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—POMC—bipolar disorder	2.75e-06	1.09e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—INS—bipolar disorder	2.73e-06	1.08e-05	CbGpPWpGaD
